Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection
Development of the antibody response in acute HIV-1 infection
Tc1 effector diversity shows dissociated expression of granzyme B and interferon-γ in HIV infection
Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients
Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cells
Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire
Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients
Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women
Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells
Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men
Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load
Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients
Reduced bone density in HIV-infected women
Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1
Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir
Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children
Frequent detection of acute primary HIV infection in men in Malawi
The impact of HIV on mortality rates in the complete UK haemophilia population
HIV prevalence in pregnant women in an ethnically diverse population in the UK
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy
HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa
Epidemiology of HIV-associated cryptococcosis in France (1985–2001)
HIV infection
Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients
Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis
Serological pattern ‘anti-hepatitis B core alone’ in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants
Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?
Long-term efficacy of the surgical treatment of buffalo hump in patients continuing antiretroviral therapy
Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine
Life-threatening reaction after first ever dose of abacavir in an HIV-1-infected patient
How flexible is tipranavir in complex with the HIV-1 protease active site?
Didanosine, interferon-alfa, and ribavirin
Antiretroviral therapy in the private sector of resource-limited settings
HIV transmission despite HIV post-exposure prophylaxis after non-occupational exposure
Multicentric Castleman's disease